Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women

American Journal of Cardiology

Volumn 82, Issue 4, 1998, Pages 409-413

  Abu Halawa, Subhi A ^a   Thompson, Kara ^a   Kirkeeide, Richard L ^a   Vaughn, William K ^a   Rosales, Oscar ^a   Fujisi, Ken ^a   Schroth, George ^a   Smalling, Richard ^a   Anderson, H Vernon ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; DISEASE-FREE SURVIVAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RETROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 0031844160     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00351-8     Document Type: Article

References (24)

1. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease:tenyear follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-762.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease:A quantitative assessment of the epidemiological evidence. Prev Med 1991;20:47-63.
3. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women:results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
4. Guetta V, Cannon RO. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996;93:1928-1937.
5. Barrett-Connor E, Bush TL. Estrogens and coronary heart disease in women. JAMA 1991;265:1861-1867.
6. Anderson HV. Estrogen therapy, atherosclerosis, and clinical cardiovascular events. Circulation 1996;94:1809-1811.
7. Postmenopausal Estrogen/Progestin Intervention Trial Writing Group. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
8. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992;69:176-178.
9. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G,Brinker JA. Ethinyl estadiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994;89:52-60.
10. Gilligan DA, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-2551.
11. Gaulin-Glaser TL, Sessa W, Sarrel P, Bender J. The effect of 17-beta-estradiol on human endothelial cell nitric oxide production (abstr). Circulation 1994;90(suppl I):30.
12. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation of prostcycline biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochem Biophys Acta 1980;619:107-118.
13. Gebara OCE, Mittleman MA, Sutherland P, Lipinska T, Matheney T, Xu P, Welty FK, Wiilson PW, Levy D, Mullen JE. Association between increased estrogen status and increased fibrinolytic potential in Framingham Offspring Study. Circulation 1995;91:1952-1958.
14. Scarabin PY, Plu-Bureau G, Bara L, Bonithon-Kopp C, Guize L, Samama M. Haemostatic variables and menopausal status:Influence of hormone replacement therapy. Thromb Haemostas 1993;70:584-587.
15. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effect of 17-beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 1993;99:209-217.
16. Rifici VA, Khachadurian AK, The inhibition of low-density lipoprotein oxidation by 17-beta-estradiol. Metabolism 1992;41:1110-1114.
17. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by estrogen- a calcium antagonistic effect? Lancet 1993;341:1264-1265.
18. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium independent relaxation of rabbit coronary artery by 17-beta-oestadiol in vitro. Br J Pharmacol 1991;104:1033-1037.
19. Proudler AJ, Ahmed AIH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995;346:89-90.
20. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 1997;79:847-850.
21. O'Keefe JH, Kim SC, Hall RR, Cochran VC, Lawhorn SL, McCallister BD. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 1997;29:1-5.
22. O'Brien JE, Peterson ED, Keeler GP, Berdan LG, Ohman EM, Faxon DP, Jacobs AK, Topol EJ, Califf RM. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1996;28:1111-1118.
23. Moraghan TJ, Grenert JP, Johnson CM, Miller VM, Fitzpatrick LA. Gender related differences in smooth muscle cell proliferation in response to estradiol and dihydrotestosterone (abstr). J Am Coll Cardiol 1995;25:14A.
24. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722-726.